statistiche ricercatore

Continente	#
EU - Europa	518
NA - Nord America	477
AS - Asia	396
SA - Sud America	88
AF - Africa	22
Continente sconosciuto - Info sul continente non disponibili	14
OC - Oceania	2
Totale	1.517

Nazione	#
US - Stati Uniti d'America	449
RU - Federazione Russa	269
SG - Singapore	157
IT - Italia	99
BR - Brasile	70
CN - Cina	62
BD - Bangladesh	57
VN - Vietnam	53
DE - Germania	32
HK - Hong Kong	28
GB - Regno Unito	23
CA - Canada	20
FR - Francia	17
IE - Irlanda	15
SE - Svezia	15
FI - Finlandia	14
NL - Olanda	10
AR - Argentina	8
IN - India	8
KR - Corea	8
ZA - Sudafrica	7
JP - Giappone	6
MX - Messico	5
TG - Togo	5
TR - Turchia	5
AT - Austria	4
NG - Nigeria	4
UA - Ucraina	4
BJ - Benin	3
CH - Svizzera	3
CZ - Repubblica Ceca	3
EC - Ecuador	3
PL - Polonia	3
VE - Venezuela	3
AU - Australia	2
ES - Italia	2
IL - Israele	2
IQ - Iraq	2
PY - Paraguay	2
SA - Arabia Saudita	2
AZ - Azerbaigian	1
BG - Bulgaria	1
CO - Colombia	1
CR - Costa Rica	1
DO - Repubblica Dominicana	1
HU - Ungheria	1
ID - Indonesia	1
JM - Giamaica	1
JO - Giordania	1
KE - Kenya	1
LB - Libano	1
LK - Sri Lanka	1
LT - Lituania	1
MA - Marocco	1
PH - Filippine	1
PT - Portogallo	1
RS - Serbia	1
UG - Uganda	1
UY - Uruguay	1
XK - ???statistics.table.value.countryCode.XK???	1
Totale	1.504

Nome	#
Cost-effectiveness and quality of life analysis of laparoscopic and robotic distal pancreatectomy: a propensity score-matched study	195
Epidemiology, clinical features and diagnostic work-up of cystic neoplasms of the pancreas: Interim analysis of the prospective PANCY survey	170
Futility of Up-Front Resection for Anatomically Resectable Pancreatic Cancer	167
Benchmarking of minimally invasive distal pancreatectomy with splenectomy: European multicentre study	148
REDISCOVER International Guidelines on the Perioperative Care of Surgical Patients With Borderline-resectable and Locally Advanced Pancreatic Cancer	132
Survival after active surveillance versus upfront surgery for incidental small pancreatic neuroendocrine tumours	129
Cure Probabilities After Resection of Pancreatic Ductal Adenocarcinoma: A Multi-Institutional Analysis of 2554 Patients	129
Corrigendum: Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients resected after neoadjuvant therapy: a retrospective, multicenter analysis	128
Outcomes of a 3-year prospective surveillance in individuals at high-risk for pancreatic cancer	123
Author response to: Survival after active surveillance versus upfront surgery for incidental small pancreatic neuroendocrine tumours	102
Adequate lymphadenectomy and adjuvant capecitabine warrant survival benefit in gallbladder cancer	94
Totale	1.517

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	13	0	6	0	2	0	0	0	0	0	0	2	3
2022/2023	68	2	6	6	9	3	18	0	9	7	0	5	3
2023/2024	77	3	3	5	14	8	12	6	2	2	3	16	3
2024/2025	239	9	7	12	35	6	3	31	14	32	22	20	48
2025/2026	1.017	47	74	48	171	254	53	72	50	87	56	58	47
2026/2027	71	15	56	0	0	0	0	0	0	0	0	0	0
Totale													1.517

CATALOGO DEI PRODOTTI DELLA RICERCA